Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Gardedam Therapeutics gets public listing, changes name after merger with Canadian shell

Executive Summary

As a vehicle to go public, Gardedam Therapeutics Inc. (chaperone therapeutics for neurodegenerative diseases) is acquiring public Canadian shell company Lion Consulting Group Inc. through a reverse merger. The combined company changed its name to Cantabio Pharmaceuticals Inc., which will now operate under that name and trade on the OTC exchange under the symbol CTBO.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Full Acquisition
    • Includes Contract
    • Payment Includes Stock
    • Reverse Acquisition

Related Companies